NCT05048212
- Conditions
- Adenocarcinoma, Brain Diseases, Brain Metastases, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT07402109
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Erasmus MC Rotterdam, South Holland, Netherlands
NCT06503614
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- Weill Cornell Medical Center New York, United States
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
NCT06567743
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High-Risk Non-Muscle-Invasive Bladder Cancer, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Arizona Urology Specialty Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Arkansas Urology Little Rock, Arkansas, United States
Recruiting
Bladder EpiCheck Product Development Study
NCT07514143
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
- Locations
-
- Om Research LLC San Diego, California, United States
- Chesapeake Urology Research Associates Towson, Maryland, United States
NCT07514897
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Chaoyang District, China
NCT06444815
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +56 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health Orange, California, United States
- University of Miami Miami, Florida, United States
- Community Health Network Indianapolis, Indiana, United States
NCT04715191
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
NCT06376669
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
NCT07401875
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, HC-7366, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States